| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > The Money Is In What List? |
|
Just Other Articles - The Money Is In What List?
Internet marketers and gurus have been telling us for years that the money is in the list, but what does that really mean? Upon scouring the Internet for answers I have come to discover some alarming secr According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ets to this cliché. While the majority will preach and teach about buying leads and implementing tactical methods to list building fantasies that rarely generate sales, the successful ones always ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eem to have an edge over the amateurs. I believe this success comes from cutting straight through the whimsical theories that many of these Internet marketers can't logically prove or explain. I have num lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. erous email accounts from several of the top email providers. My accounts are constantly bombarded with emails from thousands of Internet marketers. They come from all over the world. While one guru from here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe anada is trying to sell me on an insightful e-book with the latest list building techniques another one from Australia is attempting to sell me the same information in a different product. I was recently d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro presented with opportunities to attend a flurry of SEO webinars from the U.K and U.S. at impressive prices and with tasteful bonuses. Don't get me wrong. I have intentionally solicited myself to all of t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ese email lists and distributed them over several email accounts for tracking purposes. I feel it is beneficial to my business to stay updated and informed of all the latest product releases and services. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi It serves my business well to know what is happening in the e-business world. What concerns me, however, is the lack of overall standards many of these so called gurus advocate. If I were to start a fre nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically newsletter about home electronics and offer my subscribers the option to receive additional newsletters from third party publishers I would most likely find a great deal of common interests between my su and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ bscribers and my affiliates. This is normal because not everyone who's interested in reading about home electronics is ONLY interested in reading about home electronics. Many readers might care to know mo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e about home furnishing or gardening, for example. That enables me to provide fresh leads through an alliance company. In turn when my alliance releases their newsletter they will be able to throw fresh ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a eads my way. This creates lead crossfire. What some marketers have failed to notice is that this crossfire will only move the traffic of leads, thus economizing on potential subscribers - not potential bu dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod yers. This does not conclude the list building effort. In order to secure your leads you will need to present them with unique front-end offers. Keep in mind that these leads are merely passing you by in cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin a flow of traffic that led them your way. They have not come walking directly to your front door and so they have no reason to stop and show interest in your business unless you're offering them something tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen that the other guys can't get. Think about it. Say you happened to find yourself subscribing to a particular e-zine that captured your interest. That e-zine then sent you an offer from a sponsor that al t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ows you to subscribe to their list. You visit the sponsor's website and find that, while the offer is appealing, you choose to postpone the subscription for a later time. That later time is likely to neve ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r come around. Do you know why? The answer is simple. You retain the option of subscribing at any given time because you know that you will gain the same benefits as a subscriber of two years your senior y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products or two years your junior - regardless of when you subscribe. Leads that are generated for you are very different from leads that you generate yourself. You should never underestimate, or over estimate, th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e power of opt-in lists. Meaning, you can neither rely fully on your own lists, nor on those of others. List sharing is a lot like road building. You must learn to maximize on traffic and not congestion. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Your biggest lesson from this is learning to treat your leads differently. As they come to you in different ways - from different sources - they should be seen as different marketing channels all-together tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Is Your Ladder Against the Wrong Wall?
|